intervention: Memantine tablets for treatment group for 3 weeks orally(5mg/day for the first week and 10 mg/ day for the next two weeks)
Sponsors
Tehran University of Medical sciences
Phase 2
Efficacy of Memantine [N- Methyl- D- Aspartate (NMDA) receptor antagonist] versus placebo in acute non arteritic anterior ischemic optic neuropathy (NAION)
Active, not recruitingACTRN12607000181404
Start: 2006-06-01Target: 44Updated: 2020-01-13
The effects of memantine versus placebo on visual functions after scleral buckling for regmatogenous retinal detachment (RRD)
Active, not recruitingACTRN12609000111279
Start: 2008-02-20Target: 60Updated: 2020-01-13